|1.||Chini, Valentina: 1 article (04/2007)|
|2.||Gornati, Rosalba: 1 article (04/2007)|
|3.||Bernardini, Giovanni: 1 article (04/2007)|
|4.||Schiaffino, Eugenio: 1 article (04/2007)|
|5.||Rimoldi, Simona: 1 article (04/2007)|
|6.||Meregalli, Maurizio: 1 article (04/2007)|
|7.||Abate, Laura E: 1 article (09/2006)|
|8.||Mukherjee, Purna: 1 article (09/2006)|
|9.||Seyfried, Thomas N: 1 article (09/2006)|
09/01/2006 - "Ganglioside distribution was altered in CT-2A tumor cells using an antisense construct to beta-1,4-N-acetylgalactosaminyltransferase (GalNAc-T), a key enzyme that uses the simple ganglioside GM3 as a substrate for the synthesis of the more complex gangliosides, GM2, GM1 and GD1a. "
10/25/1994 - "This cell line expresses high levels of GM2 as well as GM3 but no GD3 or GD2 and was constructed from mouse B16 melanoma cells transfected with the polyoma large tumor antigen gene (KF3027) and the previously cloned beta-1,4-N-acetylgalactosaminyltransferase (EC 126.96.36.199) cDNA. "
|3.||Melanoma (Melanoma, Malignant)
|4.||Intestinal Neoplasms (Intestinal Cancer)
|5.||Colonic Neoplasms (Colon Cancer)
|1.||Complementary DNA (cDNA)
|2.||Messenger RNA (mRNA)